Foreign Regulators Rap More Indian Firms Over Data Integrity
This article was originally published in PharmAsia News
Executive Summary
Three more Indian pharmaceutical players have been pulled up by overseas regulators over data integrity issues in another blow to the reputation of the flagship industry.